Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Miraca reports higher annual net income, provides annual outlook

Miraca Holdings Inc. has reported that net income for the year ended March 31, 2015 was JPY16 billion, or JPY274.82 per share, compared to JPY15.32 billion, or JPY261.48 per share, for the year ended March 31, 2014. For fiscal year ending March 31, 2016, the company expects net income of JPY16.9 billion, or JPY297.07 per share, and net sales of JPY210 billion.

Published By MarketLine
22 May 2015
NewsWire
NewsWire

Lundbeck reports loss for Q1, provides guidance for 2015

H Lundbeck A/S, a Denmark-based pharmaceutical company, has reported that loss for the first quarter ended March 31, 2015 was DKK81 million, or DKK0.41 loss per share, compared to a profit of DKK331 million, or DKK1.69 per share, for the same quarter ended March 31, 2014. For 2015, the company expects core revenue to be in the range of DKK13.2 billion to DKK13.7 billion.

Published By MarketLine
22 May 2015
NewsWire
NewsWire

DENTSPLY Q1 net income decreases

DENTSPLY International Inc., a manufacturer of dental equipment, has reported that net income attributable to the company for the first quarter ended March 31, 2015 was $63.96 million, or $0.45 per diluted share, compared to $72.88 million, or $0.50 per diluted share, for the same quarter ended March 31, 2014.

Published By MarketLine
22 May 2015
NewsWire
NewsWire

ARIAD Pharmaceuticals Q1 net loss increases

ARIAD Pharmaceuticals, Inc. has reported that net loss for the first quarter ended March 31, 2015 was $52.68 million, or $0.28 loss per share, compared to a net loss of $49.82 million, or $0.27 loss per share, for the same quarter ended March 31, 2015.

Published By MarketLine
22 May 2015
NewsWire
NewsWire

Sequenom reports net earnings for Q1

Sequenom, Inc., a molecular diagnostic testing and genetics analysis company, has reported that net earnings for the first quarter ended March 31, 2015 were $14.28 million, or $0.11 per diluted share, compared to a net loss of $15.67 million, or $0.13 loss per diluted share, for the same quarter ended March 31, 2014.

Published By MarketLine
22 May 2015
NewsWire
NewsWire

Alnylam Pharmaceuticals Q1 net loss decreases

Alnylam Pharmaceuticals, Inc. has reported that net loss for the first quarter ended March 31, 2015 was $50.78 million, or $0.62 loss per share, compared to a net loss of $250.94 million, or $3.70 loss per share, for the same quarter ended March 31, 2014.

Published By MarketLine
22 May 2015
NewsWire
NewsWire

Asterias Biotherapeutics Q1 net loss increases

Asterias Biotherapeutics, Inc., a biotechnology company, has reported that net loss for the first quarter ended March 31, 2015 was $2.97 million, or $0.09 loss per share, compared to a net loss of $2.29 million, or $0.07 loss per share, for the same quarter ended March 31, 2014.

Published By MarketLine
22 May 2015
NewsWire
NewsWire

Stada Arzneimittel Q1 net income decreases

Stada Arzneimittel AG, a pharmaceutical company, has reported that earnings after taxes distributable to shareholders for the first quarter ended March 31, 2015 was E21.21 million, or E0.35 per diluted share, compared to E34.98 million, or E57 per diluted share, for the same quarter ended March 31, 2014.

Published By MarketLine
22 May 2015
NewsWire
NewsWire

Jazz Pharmaceuticals reports Q1 net income, provides annual outlook

Jazz Pharmaceuticals plc has reported that net income attributable to the company for the first quarter ended March 31, 2015 was $70.70 million, or $1.12 per diluted share, compared to a net loss attributable to the company of $92.65 million, or $1.58 loss per diluted share, for the same quarter ended March 31, 2014. For 2015, the company expects GAAP net income attributable to the company to be in the range of $5.17 to $5.70 per diluted share.

Published By MarketLine
22 May 2015
NewsWire
NewsWire

Kindred Healthcare reports net loss for Q1, provides guidance for Q2

Kindred Healthcare, Inc., a provider of post-acute care services, has reported that net loss attributable to stockholders for the first quarter ended March 31, 2015 was $146.83 million, or $1.84 loss per share, compared to a net income attributable to stockholders of $8.02 million, or $0.15 per share, for the same quarter ended March 31, 2014. For the second quarter of 2015, the company expects core diluted earnings per share from continuing operations to be between $0.27 and $0.37.

Published By MarketLine
22 May 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.